Litcius/Paper detail

Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance

Bin Du, Mei Zheng, Huizhen Ma, Jingshu Huang, Qingqing Jiao, Yimeng Bai, Mengmeng Zhao, Jie Zhou

2022Journal of Nanobiotechnology43 citationsDOIOpen Access PDF

Abstract

Abstract Multidrug resistance is still a major obstacle to cancer treatment. The most studies are to inhibit the activity of the drug transporter P-glycoprotein (P-gp), but the effect is not ideal. Herein, a nanosystem was built based on cascade catalytic consumption of cholesterol. Cholesterol oxidase (natural enzyme, COD) was immobilized on the carrier (NH 2 -MIL-88B, MOF) through amide reaction, COD catalyzed the consumption of cholesterol, the reaction product H 2 O 2 was further produced by the MOF with its peroxidase-like activity to produce hydroxyl radicals (•OH) with killing effect. Due to the high expression of CD44 receptor on the surface of tumor cells, we encapsulated chondroitin sulfate gel shell (CS-shell) with CD44 targeting and apoptosis promoting effect on the surface of DOX@MOF-COD nanoparticles, which can accurately and efficiently deliver the drugs to the tumor site and improve the effect of reversing drug resistance. Taking drug-resistant cell membrane as "breakthrough", this paper will provide a new idea for reversing multidrug resistance of tumor. Graphical Abstract

Topics & Concepts

ChemistryMultiple drug resistanceCancer cellCD44BiochemistryGlucose oxidaseEnzymeCancerCellBiologyAntibioticsGeneticsNanoplatforms for cancer theranosticsCancer, Lipids, and MetabolismPeptidase Inhibition and Analysis
Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance | Litcius